Anika’s New Launches Set Stage for 2023 and Beyond

Anika Therapeutics reported 4Q22 orthopedic sales of $38.1 million, +15.4% compared to 4Q21. For the full year 2022, the company's orthopedic sales totaled $148.3 million, +7.4% compared to the prior year.

Higher elective procedure volumes and accelerating Tactoset sales drove growth in Anika's joint preservation business. Tactoset,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us